2024 annual financial data
Lantern Pharma 2024 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -22,216,437 USD and net income was -20,781,213 USD.
Operating cash flow was -17,813,201 USD.
Get free Lantern Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -22,216,437 USD
- Net income
- -20,781,213 USD
- Operating cash flow
- -17,813,201 USD